Institutional Ownership Pyxis Oncology, Inc. (PYXS)
This table provides information about the institutional ownership of Pyxis Oncology, Inc. (PYXS). We have compiled data on the 99 institutions that hold shares in the stock, with a total of 24.5 Million shares, which have been reported (via 13F filing form) to have a value of $26.2 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
Laurion Capital Management LP
New York, NY |
Feb 14, 2025 Q4 2024 |
3,625,974
shares
|
$3.88 Million
0.11% of portfolio
|
Q3 2024
Reduced 6.09%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Feb 14, 2025 Q4 2024 |
2,980,906
shares
|
$3.19 Million
0.0% of portfolio
|
Q4 2024
Added 56.32%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,785,895
shares
|
$2.98 Million
0.0% of portfolio
|
Q2 2024
Added 766.09%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
2,436,728
shares
|
$2.61 Million
0.0% of portfolio
|
Q1 2025
Reduced 0.18%
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,082,449
shares
|
$1.16 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.21%
|
|
Palo Alto Investors LP
Palo Alto, CA |
Feb 14, 2025 Q4 2024 |
1,037,421
shares
|
$1.11 Million
0.26% of portfolio
|
Q4 2024
Added 510.25%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
944,168
shares
|
$1.01 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.74%
|
|
Abrdn PLC
|
Jan 24, 2025 Q4 2024 |
913,045
shares
|
$976,958
0.0% of portfolio
|
Q3 2024
Added 28.91%
|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
708,303
shares
|
$757,884
0.07% of portfolio
|
Q1 2022
Added 424.67%
|
|
Ikarian Capital, LLC
Dallas, TX |
Feb 14, 2025 Q4 2024 |
613,253
shares
|
$656,180
0.16% of portfolio
|
Q4 2024
Reduced 35.95%
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Feb 14, 2025 Q4 2024 |
601,940
shares
|
$644,075
0.0% of portfolio
|
Q4 2024
Added 57.23%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
446,699
shares
|
$477,967
0.0% of portfolio
|
Q4 2024
Added 1489.56%
|
|
683 Capital Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
415,000
shares
|
$444,050
0.05% of portfolio
|
Q4 2024
Added 0.08%
|
|
Pier 88 Investment Partners LLC
San Francisco, CA |
May 06, 2025 Q1 2025 |
390,960
shares
|
$418,327
0.5% of portfolio
|
Q1 2025
Added 296.55%
|
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
Feb 14, 2025 Q4 2024 |
382,606
shares
|
$409,388
0.02% of portfolio
|
Q2 2023
Reduced 27.9%
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
378,586
shares
|
$405,087
0.0% of portfolio
|
Q4 2024
Reduced 3.92%
|
|
Ridgeback Capital Investments L.P.
Miami Beach, FL |
Feb 14, 2025 Q4 2024 |
359,231
shares
|
$384,377
100.0% of portfolio
|
Q4 2024
New holding
|
|
Decheng Capital LLC
Menlo Park, CA |
May 07, 2025 Q1 2025 |
326,810
shares
|
$349,686
0.09% of portfolio
|
Q4 2023
New holding
|
|
American Century Companies Inc
Kansas City, MO |
Feb 11, 2025 Q4 2024 |
299,937
shares
|
$320,932
0.0% of portfolio
|
Q4 2024
Added 88.12%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
293,354
shares
|
$313,888
0.0% of portfolio
|
Q4 2024
Added 82.96%
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
269,995
shares
|
$288,894
0.01% of portfolio
|
Q4 2024
Added 1.77%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
242,731
shares
|
$259,722
0.0% of portfolio
|
Q4 2024
Added 58.39%
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
188,462
shares
|
$201,654
0.01% of portfolio
|
Q4 2024
Reduced 62.93%
|
|
Boothbay Fund Management, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
181,042
shares
|
$193,714
0.01% of portfolio
|
Q4 2024
Reduced 36.17%
|
|
Goldman Sachs Group Inc
New York, NY |
May 09, 2025 Q1 2025 |
160,830
shares
|
$172,088
0.0% of portfolio
|
Q1 2025
Reduced 12.92%
|